Last updated 10 days ago

Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis

182 patients around the world
Available in Argentina, Chile, United States
Total study duration per participant will be up to 58 weeks, including a screening period of up to 4 weeks, a treatment period up to 52 weeks and a post-treatment follow-up period of 2 weeks.
Sanofi
182Patients around the world

This study is for people with

Ulcerative colitis

Requirements for the patient

To 75 Years
All Gender

Medical requirements

LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy